Parnaparin sodium

帕肝素钠

Report date: 2022/01/14 13:23:58

Base Information

Drug NameParnaparin sodium
Drug Alias NameFluxumMinidaltonLowhepaOP-2123CB-01-05
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIIProthrombinCoagulation factor X
Therapy Area/IndicationsThrombophlebitisThrombosisInfertility
Global Approved IndicationsThrombosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryItaly
Original Approved Date1993/01/01
Country/TerritoryPortugalItalyGreece
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOpocrin SpaAlfasigma Spa
China Registration ClassN/A

Develop Information

Active CompaniesAlfasigma Usa Inc
Inactive CompaniesIRCCS Azienda Ospedaliero-Universitaria di BolognaIstituto Clinico Humanitas
Active IndicationsThrombosis
Inactive IndicationsThrombophlebitisInfertility

Other Information

ATC CodeB01AB07
Related LinksWikipediaDrugBankKEGG